Changmeng Cai

5.6k total citations
55 papers, 3.3k citations indexed

About

Changmeng Cai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Changmeng Cai has authored 55 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 39 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Changmeng Cai's work include Prostate Cancer Treatment and Research (49 papers), Ubiquitin and proteasome pathways (18 papers) and Estrogen and related hormone effects (14 papers). Changmeng Cai is often cited by papers focused on Prostate Cancer Treatment and Research (49 papers), Ubiquitin and proteasome pathways (18 papers) and Estrogen and related hormone effects (14 papers). Changmeng Cai collaborates with scholars based in United States, Canada and China. Changmeng Cai's co-authors include Steven P. Balk, Shaoyong Chen, Sen Chen, Housheng Hansen He, Hongyun Wang, Peter S. Nelson, Xin Yuan, Shuai Gao, Lirim Shemshedini and Myles Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Changmeng Cai

53 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changmeng Cai United States 29 2.2k 1.8k 964 600 589 55 3.3k
Hannelore V. Heemers United States 23 1.8k 0.8× 1.7k 0.9× 1.2k 1.2× 572 1.0× 647 1.1× 45 3.2k
Marcus V. Cronauer Germany 32 2.3k 1.0× 1.7k 0.9× 779 0.8× 957 1.6× 745 1.3× 73 3.8k
Lucy J. Schmidt United States 24 1.5k 0.7× 1.6k 0.9× 608 0.6× 500 0.8× 629 1.1× 32 2.7k
Changxue Lu United States 25 1.9k 0.9× 1.1k 0.6× 900 0.9× 772 1.3× 348 0.6× 48 2.8k
Scott M. Dehm United States 37 3.7k 1.7× 2.7k 1.5× 1.5k 1.5× 1.1k 1.9× 1.1k 1.8× 116 5.2k
Pasi A. Koivisto Finland 33 2.9k 1.3× 2.7k 1.5× 1.1k 1.2× 929 1.5× 1.3k 2.2× 64 5.0k
Donald J. Vander Griend United States 31 1.2k 0.5× 1.5k 0.8× 596 0.6× 243 0.4× 307 0.5× 75 2.7k
Holly M. Nguyen United States 21 1.3k 0.6× 934 0.5× 612 0.6× 238 0.4× 223 0.4× 55 2.1k
Jos Veldscholte Netherlands 17 1.3k 0.6× 1.1k 0.6× 398 0.4× 797 1.3× 926 1.6× 20 2.3k

Countries citing papers authored by Changmeng Cai

Since Specialization
Citations

This map shows the geographic impact of Changmeng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changmeng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changmeng Cai more than expected).

Fields of papers citing papers by Changmeng Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changmeng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changmeng Cai. The network helps show where Changmeng Cai may publish in the future.

Co-authorship network of co-authors of Changmeng Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Changmeng Cai. A scholar is included among the top collaborators of Changmeng Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changmeng Cai. Changmeng Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, Nicolas, Dong Han, Mu‐Qing Li, et al.. (2025). Voluntary Exercise Attenuates Tumor Growth in a Preclinical Model of Castration-Resistant Prostate Cancer. Medicine & Science in Sports & Exercise. 57(8). 1732–1742.
2.
Han, Wanting, Nancy Patten, Susan Patalano, et al.. (2025). Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient Cells. Molecular Cancer Therapeutics. 24(5). 772–783.
3.
Cai, Changmeng, et al.. (2024). Effects of exercise training on prostate cancer: Current evidence and potential molecular mechanisms. SHILAP Revista de lepidopterología. 1(3). 160–169. 2 indexed citations
4.
Wang, Zifeng, Scott L. Townley, Mu‐Qing Li, et al.. (2024). FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer. Nature Communications. 15(1). 4914–4914. 13 indexed citations
5.
Wang, Zifeng, Jessica Petricca, Sujun Chen, et al.. (2023). SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1. Proceedings of the National Academy of Sciences. 120(33). e2220472120–e2220472120. 9 indexed citations
6.
Han, Wanting, Zifeng Wang, Dong Han, et al.. (2023). LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer. Cancer Research. 83(10). 1684–1698. 52 indexed citations
7.
Han, Wanting, Zifeng Wang, Susan Patalano, et al.. (2023). Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression. Cancer Research Communications. 3(8). 1716–1730. 1 indexed citations
8.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer. Molecular Therapy. 30(4). 1628–1644. 25 indexed citations
9.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition. Oncogene. 41(6). 852–864. 26 indexed citations
10.
Han, Dong, Susan Patalano, Shuai Gao, et al.. (2021). Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression. Cancer Research. 81(14). 3766–3776. 4 indexed citations
11.
Chen, Sen, Changmeng Cai, Adam G. Sowalsky, et al.. (2018). BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer. Cancer Research. 78(18). 5203–5215. 21 indexed citations
12.
Nyquist, Michael D., Alexandra Corella, Ilsa M. Coleman, et al.. (2017). Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155. Molecular Cancer Research. 15(5). 521–531. 15 indexed citations
13.
Gao, Shuai, Yanfei Gao, Housheng Hansen He, et al.. (2016). Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein. Cell Reports. 17(4). 966–976. 71 indexed citations
14.
Gao, Shuai, Huihui Ye, Hongyun Wang, et al.. (2016). ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. Clinical Cancer Research. 22(14). 3672–3682. 34 indexed citations
15.
Botta, Ginevra, Shuai Gao, Tiantian Li, et al.. (2015). PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy. Cancer Research. 75(10). 1944–1948. 46 indexed citations
16.
Yu, Ziyang, Sen Chen, Adam G. Sowalsky, et al.. (2014). Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer. Clinical Cancer Research. 20(6). 1590–1600. 148 indexed citations
17.
Sowalsky, Adam G., Shuai Gao, Changmeng Cai, et al.. (2014). Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors. Clinical Cancer Research. 21(6). 1273–1280. 139 indexed citations
18.
Chen, Sen, Xinnong Jiang, Christina Gewinner, et al.. (2013). Tyrosine Kinase BMX Phosphorylates Phosphotyrosine-Primed Motif Mediating the Activation of Multiple Receptor Tyrosine Kinases. Science Signaling. 6(277). ra40–ra40. 18 indexed citations
19.
Cai, Changmeng, Sen Chen, Patrick Kwok‐Shing Ng, et al.. (2011). Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors. Cancer Research. 71(20). 6503–6513. 349 indexed citations
20.
Cai, Changmeng, Hongyun Wang, Youyuan Xu, Shaoyong Chen, & Steven P. Balk. (2009). Reactivation of Androgen Receptor–Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer. Cancer Research. 69(15). 6027–6032. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026